The promise and challenges of immune agonist antibody development in cancer
Year: 2018
Type: review
Source: Nature Reviews Drug Discovery
DOI: 10.1038/nrd.2018.75
Authors: Patrick A. Mayes, Kenneth W. Hance, Axel Hoos
Institutions: GlaxoSmithKline (United States), Incyte (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2807748927
